CVS Health reported strong financial results for Q4 and full year 2022. Total revenues increased 10% to $322.5 billion for the full year. GAAP diluted EPS from continuing operations was $3.14, and Adjusted EPS was $8.69. The company generated $13.5 billion of cash flow from operations.For Q4, total revenues grew 9.5% year-over-year to $83.8 billion. GAAP diluted EPS from continuing operations was $2.30, and Adjusted EPS was $1.99. CVS Health returned $2.9 billion to shareholders through dividends during 2022.The company provided a 2023 full year GAAP diluted EPS guidance range of $7.73 to $7.93, and reaffirmed its Adjusted EPS guidance range of $8.70 to $8.90. CVS Health expects to generate cash flow from operations of $12.5 billion to $13.5 billion in 2023.

CVS Health reported strong financial results for Q4 and full year 2022. Total revenues increased 10% to $322.5 billion for the full year. GAAP diluted EPS from continuing operations was $3.14, and Adjusted EPS was $8.69. The company generated $13.5 billion of cash flow from operations.For Q4, total revenues grew 9.5% year-over-year to $83.8 billion. GAAP diluted EPS from continuing operations was $2.30, and Adjusted EPS was $1.99. CVS Health returned $2.9 billion to shareholders through dividends during 2022.The company provided a 2023 full year GAAP diluted EPS guidance range of $7.73 to $7.93, and reaffirmed its Adjusted EPS guidance range of $8.70 to $8.90. CVS Health expects to generate cash flow from operations of $12.5 billion to $13.5 billion in 2023.